Highlights Standard BioTools Inc.

Equities

LAB

US34385P1084

Real-time Estimate Cboe BZX Other stock markets 03:33:31 2024-05-10 pm EDT			5-day change	1st Jan Change
2.425 ^USD	+0.62%		-3.39%	+9.73%

May. 08	Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08	Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M	May. 08	MT
Standard BioTools Inc. Reaffirms Revenue Guidance for the Fiscal Year 2024	May. 08	CI
Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25	MT
Sector Update: Health Care	Apr. 25	MT
Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction	Apr. 25	MT
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	Apr. 08	CI
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	Apr. 04	MT
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	Apr. 04	MT
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	Feb. 28	MT
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	Feb. 26	CI
Standard Biotools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine	Feb. 07	CI
Standard Biotools Inc. Provides Revenue Guidance for the Fourth Quarter and full year 2023	Jan. 08	CI
Standard BioTools Says Merger With SomaLogic Completed	Jan. 05	MT
SomaLogic, Standard BioTools Receive Shareholder Approvals for Pending Merger	Jan. 05	MT
Standard BioTools Inc. completed the acquisition of SomaLogic, Inc..	Jan. 04	CI
Standard BioTools Inc.'s Equity Buyback announced on November 28, 2022, has expired.	Dec. 30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Standard BioTools Inc.

Equities

LAB

US34385P1084

Highlights

Filters